Tragedy struck as Susan McGowan, a 58 year old NHS bed manager, died after taking two doses of the weight loss drug Mounjaro, which has been hailed as the "King Kong" of slimming injections. Despite being prescribed to over 250,000 patients since its introduction by the NHS, Susan opted to purchase the drug privately. Following her second jab, she suffered severe stomach pains and sickness , leading to her death in the A&E department where she worked at University Hospital Monklands in North Lanarkshire, Scotland.
Her niece, Jade Campbell, remembered Susan as a "bubbly" and "generous" individual with a "huge personality," telling the BBC : "It was so quick. I still find myself thinking, 'has that actually happened? ' Susan had always carried a wee bit of extra weight but there were never any health concerns. She wasn't on any other medication.
" "She was healthy. Susan was such a bubbly person. She was really generous, she was really kind and she was the life of the party - a huge personality.
They said she had the biggest laugh in the hospital." Weight-loss injections, known as GLP-1 agonists, which slow digestion and curb appetite, are in the spotlight following the tragic death of Susan attributed partly to Mounjaro, also called tirzepatide. These jabs imitate hunger-regulating hormones, particularly glucagon-like peptide 1 (GLP-1).
Susan's death certificate cites multiple organ failure, septic shock, and pancreatitis, with Mounjaro usage recorded as a contributing element,.
